SMI
12.822,24
PKT
+50,61
PKT
+0,40
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.09.14 | Novartis Underweight | Morgan Stanley | |
| 16.09.14 | Roche overweight | Morgan Stanley | |
| 15.09.14 | Novartis buy | Jefferies & Company Inc. | |
| 15.09.14 | Roche buy | Jefferies & Company Inc. | |
| 15.09.14 | UBS Equal weight | Barclays Capital | |
| 12.09.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 11.09.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 11.09.14 | Roche overweight | JP Morgan Chase & Co. | |
| 11.09.14 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.09.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.09.14 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 10.09.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 10.09.14 | Zurich Insurance neutral | Jefferies & Company Inc. | |
| 10.09.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 10.09.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 10.09.14 | UBS overweight | JP Morgan Chase & Co. | |
| 09.09.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 09.09.14 | Swiss Re buy | Deutsche Bank AG | |
| 09.09.14 | UBS buy | Deutsche Bank AG | |
| 09.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 09.09.14 | Swiss Re Underperform | Credit Suisse Group | |
| 08.09.14 | Zurich Insurance Hold | Deutsche Bank AG | |
| 05.09.14 | UBS Equal-Weight | Morgan Stanley | |
| 05.09.14 | UBS overweight | Morgan Stanley | |
| 05.09.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.09.14 | UBS Neutral | UBS AG | |
| 04.09.14 | Novartis Outperform | BNP PARIBAS | |
| 04.09.14 | Roche buy | UBS AG | |
| 03.09.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 03.09.14 | Givaudan buy | UBS AG | |
| 03.09.14 | Novartis Halten | Independent Research GmbH | |
| 03.09.14 | ABB (Asea Brown Boveri) buy | Merrill Lynch & Co., Inc. | |
| 03.09.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 02.09.14 | Nestlé Halten | Independent Research GmbH | |
| 02.09.14 | UBS overweight | JP Morgan Chase & Co. | |
| 02.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 01.09.14 | UBS buy | Deutsche Bank AG | |
| 01.09.14 | UBS buy | Deutsche Bank AG | |
| 01.09.14 | Novartis buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.